Year: 2024

CALGARY, Alberta, Dec. 02, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company”) a North American leading manufacturer and supplier of technologically advanced cellular concrete products, today announces the retirement of Mr. Jeff Kendrick, President and Chief Executive Officer, effective November 29, 2024. Mr. Kendrick has also retired from the Board of Directors of the Company effective November 29, 2024. Mr. Kendrick has chosen to retire for personal and family reasons. Mr. Kendrick founded the Company in 1999 and took the Company public in 2005 through a reverse takeover. Mr. Kendrick has led the Company for 25 years including through many stages of growth both in Canada and the United States. Under Mr. Kendrick’s leadership, the Company has prospered and grown. Mr. Kendrick successfully...

WASHINGTON, Dec. 02, 2024 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Investor Access Event in South Africa from January 14-16, 2025. All investors are invited to request a registration to attend the Investor Access Event. ASP Isotopes values transparency and open communication with all stakeholders and counterparties. During 2024, the Company welcomed over 60 investors and corporate clients to its facilities in South Africa. The timing of the event for investors departing from the USA allows for the following schedule:  Sun, Jan 12 (evening)         Mon, Jan 13 (evening)         Tue, Jan 14 (all...

VANCOUVER, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation intelligent systems, announces milestones for the year end update of significant progress in research and product development. “This has been a transformative year for VERSES, but we are not done yet,” said Gabriel René, founder and CEO of VERSES. “Over the next few weeks, we intend to share our achievements from research, including benchmark results from the Atari 10K challenge, a demonstration of Genius that highlights the pragmatic value it can deliver today beyond current LLMs, and general Company and commercial updates.” Benchmark: Atari 10K Progress VERSES is seeing very positive results during its internal testing...

DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) — Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing for drugs of abuse, today announced that, following the approval of the Company’s stockholders at its Annual Meeting of Stockholders held on November 25, 2024, the Company’s Board of Directors has approved a 1-for-5,000 reverse stock split of its common stock (the “Reverse Stock Split”) followed immediately by a 5,000-for-1 forward stock split of its common stock (the “Forward Stock Split,” and together with the Reverse Stock Split, the “Stock Split”), to be effective at 5:01 p.m. and 5:02 p.m., Eastern Time, respectively, on Tuesday, December 3, 2024. Beginning with the opening of trading on Wednesday, December 4, 2024, the Company’s common stock will continue to trade on the Nasdaq Capital...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. EDMONTON, Alberta, Dec. 02, 2024 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV: BTCW; OTCQB: BCNWF), the non-custodial bitcoin business on a mission to enable independence, is pleased to announce that it has entered into an agreement with Haywood Securities Inc. (“Haywood”) to act as lead agent and sole bookrunner, together with a syndicate of agents (the “Agents”), in connection with a best-efforts private placement of up to approximately $2,000,000 convertible debenture units (the “Debenture Units”) at a price of $1,000 per Debenture Unit (the “Offering”). Each Debenture Unit shall consist of: (i) one 8% $1,000 principal amount unsecured convertible debenture (each, a ”Debenture”); and (ii) 4,347...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer has large-scale commercial production capabilities, to support Polyrizon in future commercialization efforts Raanana, Israel, Dec. 02, 2024 (GLOBE NEWSWIRE) — Polyrizon Ltd. (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announces today the signing of a manufacturing agreement with Eurofins CDMO Amatsiaquitaine S.A.S, a leading European-based Good Manufacturing Practice (GMP) manufacturer. This collaboration will supply Clinical Trial Material (CTM) for Polyrizon’s PL-14 allergy blocker, in preparation for a clinical trial that is expected to commence in 2025. With this...

DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX), (“P10” or the “Company”), a leading private markets solutions provider, today announced the appointment of Mike Goodwin as Chief Information Officer, effective December 2, 2024. Mr. Goodwin will lead the Company’s data, technology, and infrastructure function, providing strategic leadership across the P10 platform. “As Chief Information Officer, Mike Goodwin will add critical expertise to our deep, seasoned team,” said Luke Sarsfield, P10 Chairman and Chief Executive Officer. “Mike’s extensive experience in data strategy, cybersecurity, and technology strategy will be instrumental as we continue to enhance our operational and technological capabilities. We believe his leadership will strengthen our ability to serve clients and drive innovation across the organization.” In...